Ultimax One DIM
Natural health product licensed in Canada
- Other names
- Ultimax DIM, Ultimax One DIM Estro
- Licence holder
- Ultima Sport Nutrition Inc.
- NPN or DIN-HM
- 80077997
- Status
- Active licence
- Licence date
- 1 June 2017
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 3,3'-diindolylméthane Source : 3,3'-diindolylméthane | 200 milligramme | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Hypromellose, Cellulose microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Source of antioxidants that help protect against the cell damage caused by free radicals. Helps to support/promote healthy estrogen metabolism. Helps reduce the severity and duration of symptoms associated with recurrent breast pain (cyclical mastalgia).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
If you are pregnant or breastfeeding, do not use this product.
- Précautions et mises en garde
If you are taking medications or natural health products, consult a health care practitioner prior to use. If you are attempting to conceive, consult a health care practitioner prior to use. If you have a liver disorder or if you are a female with symptoms of low estrogen (such as joint pain, mood changes, changes in libido, hot flashes, night sweats, vaginal dryness or irregular menstruations), consult a healthcare practitioner prior to use. If you develop liver-related symptoms (e.g. yellowing of the eyes and/or skin, dark urine, abdominal pain, jaundice) or symptoms of low estrogen, discontinue use and consult a health care practitioner. To exclude the diagnosis of a serious cause of hormonal imbalance, consult a health care practitioner prior to use. If symptoms persist or worsen, consult a health care practitioner.
Source
Official Health Canada record, licence 80077997
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.